A randomized phase 3 study of the efficacy and safety of reslizumab in subjects with asthma with elevated eosinophils

Authors
Category Primary study
JournalEUROPEAN RESPIRATORY JOURNAL
Year 2014
This article has no abstract
Epistemonikos ID: 1e8ca95503fa4cc728fdd7ae81db71e590be053d
First added on: Sep 29, 2017